Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

Starting soon · Not applicable

Conditions studied: COPD (With - Without Rehabilitation)

In brief

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Key facts

Study ID

NCT07752420

Run by

Green International University

People needed

52

Starts

2026-09-01

Expected to finish

2026-12-30

Last updated by the study team

2026-08-07

Who can join

Age: 50 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically diagnosed stable COPD according to GOLD criteria
• GOLD stage II or III
• No acute exacerbation within the previous four weeks
• Able to ambulate independently
• Medically cleared to participate in pulmonary rehabilitation
• Willing to provide written informed consent

You may not qualify if…

• Severe cardiovascular disease contraindicating exercise
• Recent thoracic or abdominal surgery (<6 months)
• Rib fractures or severe chest wall deformity
• Neurological disorders affecting mobility
• Active malignancy
• Severe osteoporosis with high fracture risk
• Previous Structural Integration treatment within the last year

Where it is running

• Ali Fatima Hospital — Lahore, Punjab Province, Pakistan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.